[1]Yang L, Song C, Chen Y, et al. Circular RNA circ_0103552 forecasts dismal prognosis and promotes breast cancer cell proliferation and invasion by sponging miR-1236[J]. J Cell Biochem, 2019, 120:15553-15560. [2]Zhao M, Dong G, Meng Q, et al. Circ_OMER1 enhances the inhibition of miR22 on CXCL6 to regulate the growth and aggressiveness of hepatocellular carcinoma cells[J]. J Cell Biochem, 2020, 121:4440-4449. [3]Afrin R, Arumugam S, Rahman A, et al. Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation[J]. Int Immunopharmacol, 2017, 44:174-182. [4]Zhang HD, Jiang LH, Sun DW, et al. CircRNA: a novel type of biomarker for cancer[J]. Breast Cancer, 2018, 25:1-7. [5]赵钰珊,冀梦蝶,董昱诚,等.肝细胞癌中EZH2基因相关的表观遗传调控机制[J].基础医学与临床,2022,42:864-870. [6]Yao T, Chen Q, Fu L, et al. Circular RNAs: biogenesis, properties, roles, and their relationships with liver diseases[J]. Hepatol Res, 2017, 47:497-504. [7]Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer[J]. Mol Cancer, 2017, 16:94-101. [8]黄海良,丁伟伟,李冬雪. CRNDE过表达促进人肝癌细胞系HepG2增殖和迁移[J].基础医学与临床, 2020, 40:219-223. [9]Qi H, Sun Y, Jiang Y, et al. Upregulation of circular RNA circ_0000502 predicts unfavorable prognosis in osteosarcoma and facilitates cell progression via sponging miR-1238[J]. J Cell Biochem, 2019, 5:11-19. [10]Zhang LW, Wang B, Yang JX, et al. Circ-PRMT5 stimulates migration in esophageal cancer by binding miR-203[J]. Eur Rev Med Pharmacol Sci, 2020, 24:9965-9972. [11]Yang L, Song C, Chen Y, et al. Circular RNA circ_0103552 forecasts dismal prognosis and promotes breast cancer cell proliferation and invasion by sponging miR-1236[J]. J Cell Biochem, 2019, 120:15553-15560. [12]Shen GQ, Girelli D, Li L, et al. A novel molecular diagnostic marker for familial and early-onset coronary artery disease and myocardial infarction in the LRP8 gene.[J]. Circ Cardiovasc Genet, 2014, 7:514-520. [13]Shaohang, Cai, Zejin, et al. Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome:[J]. United European Gastroenterol J, 2018, 6:558-566. [14]Frisk P, Aggefors K, Cars T, et al. Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden[J]. Eur J Clin Pharmacol, 2018, 74:971-978. [15]Mónica G, Sandra G, Miguel HK, et al. Differential roles, crosstalk and response to the antifungal protein AfpB in the three mitogen-activated protein kinases (MAPK) pathways of the citrus postharvest pathogen penicillium digitatum.[J]. Fungal Genet Biol, 2018, 124:17-28. |